Specific Biomarker for Chikungunya

by Dr. Trupti Shirole on  March 16, 2012 at 11:47 PM Chikungunya News
RSS Email Print This Page Comment bookmark
Font : A-A+

Scientists claim that delayed appearance of IgG3 antibodies (a naturally-acquired antibody) serves as a specific biomarker that increases the risk of the more severe form of Chikungunya. This discovery by A*STAR's (Agency for Science, Technology and Research) Singapore Immunology Network could aid in early and accurate prognosis of patients at risk.
 Specific Biomarker for Chikungunya
Specific Biomarker for Chikungunya

Scientists led by by Dr. Lisa Ng discovered that patients who respond to the disease at the onset with high levels of IgG3 are protected from the more severe form of chikungunya fever. While, those with a delayed IgG3 response generally have less acute symptoms at the start, but are more susceptible to chronic debilitating joint pains later on.

With the help of computational experts from A*STAR's Institute for Infocomm Research (I2R), the team also found that a very small defined segment of the Chikungunya viral protein, named E2EP3, was able to induce the natural IgG3 protective response in pre-clinical models.

Chikungunya is a mosquito-borne infectious disease endemic to Southeast Asia and Africa. There is no clinically-approved vaccine or treatment for chikungunya. It is characterised by persistent joint pain that lingers for months. Most patients recover within a week but immunocompromised patients may succumb to the disease.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Dengue and Homeopathy Chikungunya 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive